Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China
· Delayed Price · Currency is CNY 168.95
+0.20 (0.12%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Liver Disease Medication | 4.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Liver Disease Medication Growth | 24.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Circulation | 4.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Circulation Growth | 3.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cosmetics | 706.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cosmetics Growth | 11.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular and Cerebrovascular Medication | 265.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular and Cerebrovascular Medication Growth | 60.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 22.31M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | 14.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 395.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 76.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cosmetics and Daily Chemical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cosmetics and Daily Chemical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Food | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Food Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory System Medication | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory System Medication Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dermatology Medication | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dermatology Medication Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cold Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cold Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedics Medicines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anorectal Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anorectal Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 9.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 15.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 457.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | 13.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|